Search

Search Constraints

You searched for: Author/Creator Koopman, M.

Search Results

1. 1217 EORTC QLQ-C30 for cost-effectiveness research in metastatic colorectal cancer patients (mCRC): Design and validation of a mapping algorithm. (September 2015)

2. 2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis. (September 2015)

6. Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer. (December 2016)

7. Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer. (April 2017)

8. Daily practice in guideline adherence to adjuvant chemotherapy in stage III colon cancer and predictors of outcome. Issue 8 (August 2021)